Combogesic

How Does Combogesic Work?

Combogesic works through dual complementary mechanisms of action. Acetaminophen acts centrally in the brain and spinal cord, believed to inhibit prostaglandin synthesis in the CNS and modulate pain perception. Ibuprofen, an NSAID, acts peripherally by inhibiting COX-1 and COX-2 enzymes, reducing prostaglandin production at the site of tissue injury or inflammation.

Because the two drugs address different pain pathways — central and peripheral — their effects are additive and potentially synergistic. This is the pharmacological basis of multimodal analgesia. Phase 3 clinical trials demonstrated that Combogesic IV provided more than double the pain relief compared to either IV acetaminophen or IV ibuprofen used as monotherapy, with a shorter time to meaningful pain relief.

Combogesic is not an opioid and does not carry opioid-related risks. In the hospital setting, it serves as an opioid-sparing agent — clinical data showed reduced opioid usage rates in patients receiving Combogesic IV, which is a clinically meaningful advantage in the context of postoperative pain management.

How Hard Is It to Find Combogesic In Stock?

As of 2026, Combogesic is not on the FDA or ASHP drug shortage list. However, finding it at a retail pharmacy can be challenging because it is a newer brand-only medication without a generic equivalent. Distribution is still expanding, and many smaller or independent pharmacies have not added it to their regular inventory. Large chain pharmacies such as CVS, Walgreens, and Walmart are more likely to stock it.

The Combogesic IV form is not available at retail pharmacies — it is dispensed exclusively through hospital pharmacy departments and administered by clinical staff. Hospital formulary decisions determine which facilities stock it.

If you're having trouble locating Combogesic at your pharmacy, medfinder can help. medfinder contacts pharmacies near your location to find which ones currently have Combogesic in stock and texts results to you — saving you from calling every pharmacy yourself.

Who Can Prescribe Combogesic?

Combogesic is not a controlled substance, so it can be prescribed by any licensed healthcare provider without DEA scheduling restrictions. A broad range of clinicians routinely prescribe Combogesic or its clinical equivalent for acute pain management.

Primary care physicians and internal medicine physicians

Surgeons and orthopedic specialists (for postoperative pain)

Dentists (for dental procedure pain)

Emergency medicine physicians

Anesthesiologists and pain management specialists (especially for IV form)

Nurse practitioners (NPs) and physician assistants (PAs) — in most states with full prescribing authority

Telehealth availability: The oral tablet form of Combogesic can be prescribed via telehealth visits in most states, as it is not a controlled substance. Major telehealth platforms such as Teladoc and MDLive offer urgent care visits where acute pain can be evaluated and Combogesic prescribed electronically. The IV form is hospital-administered only and is not obtainable through telehealth.

Is Combogesic a Controlled Substance?

No. Combogesic is not a DEA-scheduled controlled substance. Neither acetaminophen nor ibuprofen — the two active ingredients — is classified as a controlled drug under the Controlled Substances Act. This means Combogesic can be prescribed by any licensed healthcare provider (including physicians, dentists, NPs, and PAs) without a DEA registration requirement for controlled substances.

Because it is not controlled, Combogesic can also be prescribed via telehealth without any DEA telemedicine exemption requirements. Standard prescription refill rules apply — pharmacies may allow early refills based on their policies, and there is no Schedule-based restriction on refill frequency or quantity.

Common Side Effects of Combogesic

The most frequently reported side effects from Combogesic clinical trials include:

Nausea

Vomiting

Dizziness

Headache

Constipation

Mild drowsiness (approximately 2% of patients)

IV form: infusion site pain, infusion site extravasation

Serious side effects (seek immediate medical care if any of these occur):

Acute liver failure (signs: dark urine, jaundice, upper right abdominal pain, unusual fatigue)

Heart attack or stroke (chest pain, sudden weakness, sudden severe headache)

GI bleeding (black/tarry stools, vomiting blood)

Serious skin reactions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, DRESS

Severe allergic reaction/anaphylaxis (difficulty breathing, facial swelling)

Acute kidney injury (especially in volume-depleted or elderly patients)

Final Thoughts on Combogesic

Combogesic is a clinically meaningful advancement in non-opioid pain management. By combining acetaminophen and ibuprofen in a single fixed-dose formulation, it delivers superior analgesic efficacy compared to either drug alone — with Phase 3 data showing more than double the pain relief of IV acetaminophen or IV ibuprofen monotherapy. For patients and providers, it represents a practical opioid-sparing tool with a well-characterized safety profile.

As a newer brand-only medication, Combogesic is still building nationwide pharmacy distribution. Patients who have trouble finding it at their local pharmacy should try large chain pharmacies first or ask for a special order. Those facing high out-of-pocket costs should ask their prescriber about manufacturer savings programs, check GoodRx, or ask whether separate OTC acetaminophen and ibuprofen might be an appropriate and more affordable alternative.

If you need help finding Combogesic in stock near you, medfinder is the fastest way to locate it. medfinder contacts pharmacies near your location and texts you results — no hold music, no driving to pharmacies that don't have it.